2025-05-09 20:18:05, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_001170639 2315 bp mRNA linear PRI 15-APR-2013 DEFINITION Homo sapiens cyclin-dependent kinase 20 (CDK20), transcript variant 4, mRNA. ACCESSION NM_001170639 VERSION NM_001170639.1 GI:282402174 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 2315) AUTHORS Mumert,M., Dubuc,A., Wu,X., Northcott,P.A., Chin,S.S., Pedone,C.A., Taylor,M.D. and Fults,D.W. TITLE Functional genomics identifies drivers of medulloblastoma dissemination JOURNAL Cancer Res. 72 (19), 4944-4953 (2012) PUBMED 22875024 REMARK GeneRIF: Data indicate that expression of ERAS, LHX1, and CCRK is increased in aggressive subgroups of medulloblastomas. REFERENCE 2 (bases 1 to 2315) AUTHORS Feng,H., Cheng,A.S., Tsang,D.P., Li,M.S., Go,M.Y., Cheung,Y.S., Zhao,G.J., Ng,S.S., Lin,M.C., Yu,J., Lai,P.B., To,K.F. and Sung,J.J. TITLE Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor-dependent hepatocarcinogenesis JOURNAL J. Clin. Invest. 121 (8), 3159-3175 (2011) PUBMED 21747169 REMARK GeneRIF: Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor-dependent hepatocarcinogenesis REFERENCE 3 (bases 1 to 2315) AUTHORS An,X., Ng,S.S., Xie,D., Zeng,Y.X., Sze,J., Wang,J., Chen,Y.C., Chow,B.K., Lu,G., Poon,W.S., Kung,H.F., Wong,B.C. and Lin,M.C. TITLE Functional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesis JOURNAL Eur. J. Cancer 46 (9), 1752-1761 (2010) PUBMED 20466538 REMARK GeneRIF: results suggest for the first time that CCRK is involved in colorectal cancer carcinogenesis and G1/S cell cycle transition by regulating Cdk2, cyclin E and Rb. REFERENCE 4 (bases 1 to 2315) AUTHORS Wu,G.Q., Xie,D., Yang,G.F., Liao,Y.J., Mai,S.J., Deng,H.X., Sze,J., Guan,X.Y., Zeng,Y.X., Lin,M.C. and Kung,H.F. TITLE Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma JOURNAL Int. J. Cancer 125 (11), 2631-2642 (2009) PUBMED 19672860 REMARK GeneRIF: Overexpression of CCRK is associated with ovarian carcinoma. REFERENCE 5 (bases 1 to 2315) AUTHORS Malumbres,M., Harlow,E., Hunt,T., Hunter,T., Lahti,J.M., Manning,G., Morgan,D.O., Tsai,L.H. and Wolgemuth,D.J. TITLE Cyclin-dependent kinases: a family portrait JOURNAL Nat. Cell Biol. 11 (11), 1275-1276 (2009) PUBMED 19884882 REFERENCE 6 (bases 1 to 2315) AUTHORS Qiu,H., Dai,H., Jain,K., Shah,R., Hong,C., Pain,J., Tian,B., Vatner,D.E., Vatner,S.F. and Depre,C. TITLE Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure JOURNAL J. Biol. Chem. 283 (32), 22157-22165 (2008) PUBMED 18508765 REFERENCE 7 (bases 1 to 2315) AUTHORS Wohlbold,L., Larochelle,S., Liao,J.C., Livshits,G., Singer,J., Shokat,K.M. and Fisher,R.P. TITLE The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity JOURNAL Cell Cycle 5 (5), 546-554 (2006) PUBMED 16552187 REMARK GeneRIF: Depletion of PNQALRE by >80% due to RNA interference (RNAi) impairs cell proliferation, but fails to arrest the cell cycle at a discrete point. REFERENCE 8 (bases 1 to 2315) AUTHORS Liu,Y., Wu,C. and Galaktionov,K. TITLE p42, a novel cyclin-dependent kinase-activating kinase in mammalian cells JOURNAL J. Biol. Chem. 279 (6), 4507-4514 (2004) PUBMED 14597612 REMARK GeneRIF: identification of p42, a novel cyclin-dependent kinase-activating kinase (CAK) activity in human cells; p42 is essential for the phosphorylation of Thr-160 and activation of CDK2 and is indispensable for cell growth COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from DB469301.1, CB992644.1, AK075325.1, AY904367.1, BC002655.2, AL353572.13, AI479563.1 and BM982394.1. Summary: The protein encoded by this gene contains a kinase domain most closely related to the cyclin-dependent protein kinases. The encoded kinase may activate cyclin-dependent kinase 2 and is involved in cell growth. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Dec 2009]. Transcript Variant: This variant (4) uses an alternate in-frame splice site in the 5' coding region, and an alternate splice site in the 3' coding region, which results in a frameshift compared to variant 1. This results in a shorter protein (isoform 4), compared to isoform 1. ##Evidence-Data-START## Transcript exon combination :: BC002655.2 [ECO:0000332] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end. PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-18 DB469301.1 1-18 19-409 CB992644.1 28-418 410-456 AK075325.1 202-248 457-457 AY904367.1 123-123 458-1914 BC002655.2 183-1639 1915-2112 AL353572.13 64637-64834 c 2113-2300 AI479563.1 1-188 c 2301-2315 BM982394.1 2-16 c FEATURES Location/Qualifiers source 1..2315 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="9" /map="9q22.1" gene 1..2315 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="cyclin-dependent kinase 20" /db_xref="GeneID:23552" /db_xref="HGNC:21420" /db_xref="MIM:610076" exon 1..409 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /inference="alignment:Splign:1.39.8" variation 108 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="c" /replace="g" /db_xref="dbSNP:28364934" misc_feature 188..190 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="upstream in-frame stop codon" CDS 335..1162 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /EC_number="2.7.11.22" /note="isoform 4 is encoded by transcript variant 4; cell division protein kinase 20; CAK-kinase p42; CDK-activating kinase p42; cyclin-kinase-activating kinase p42; cyclin-dependent protein kinase H; cell cycle-related kinase" /codon_start=1 /product="cyclin-dependent kinase 20 isoform 4" /protein_id="NP_001164110.1" /db_xref="GI:282402175" /db_xref="GeneID:23552" /db_xref="HGNC:21420" /db_xref="MIM:610076" /translation="
MDQYCILGRIGEGAHGIVFKAKHVETGEIVALKKVALRRLEDGFPNQALREIKALQEMEDNQYVVQLKAVFPHGGGFVLAFEFMLSDLAEVVRHAQRPLAQAQVKSYLQMLLKGVAFCHANNIVHRDLKPANLLISASGQLKIADFGLARVFSPDGSRLYTHQVATRSVGCIMGELLNGSPLFPGKNDIEQLCYVLRILGTPNPQVWPELTELPDYNKISFKEQVPMPLEEVLPDVSPQALDLLGQFLLYPPHQRIAASKLPCLPIHLSCRFLSV
" misc_feature 335..1111 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="cyclin-dependent kinase A; Provisional; Region: PLN00009" /db_xref="CDD:177649" misc_feature 341..1114 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase; Region: STKc_CCRK; cd07832" /db_xref="CDD:173736" misc_feature order(362..373,386..388,425..427,431..433,482..484, 527..529,575..586,593..595,599..604,713..715,719..721, 725..730,734..736,767..769,776..778,815..817,821..832, 887..889) /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="active site" /db_xref="CDD:173736" misc_feature order(362..373,386..388,425..427,431..433,527..529, 575..586,593..595,602..604,725..730,734..736,767..769) /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="ATP binding site [chemical binding]; other site" /db_xref="CDD:173736" misc_feature order(482..484,599..601,713..715,719..721,776..778, 815..817,821..832,887..889) /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="substrate binding site [chemical binding]; other site" /db_xref="CDD:173736" misc_feature order(764..799,812..835) /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /note="activation loop (A-loop); other site" /db_xref="CDD:173736" exon 410..523 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /inference="alignment:Splign:1.39.8" exon 524..712 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /inference="alignment:Splign:1.39.8" variation 591 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="c" /replace="t" /db_xref="dbSNP:28364953" variation 619 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="a" /replace="c" /db_xref="dbSNP:3750491" exon 713..834 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /inference="alignment:Splign:1.39.8" variation 743 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="a" /replace="g" /db_xref="dbSNP:28364955" exon 835..958 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /inference="alignment:Splign:1.39.8" variation 886 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="a" /replace="g" /db_xref="dbSNP:28364959" exon 959..1114 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /inference="alignment:Splign:1.39.8" variation 1113 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="a" /replace="g" /db_xref="dbSNP:28364963" exon 1115..2305 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /inference="alignment:Splign:1.39.8" variation 1437 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="c" /replace="t" /db_xref="dbSNP:3750492" variation 1726 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="a" /replace="g" /db_xref="dbSNP:28364970" STS 1874..2022 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /standard_name="WIAF-2079" /db_xref="UniSTS:8848" STS 1922..2087 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /standard_name="A005E17" /db_xref="UniSTS:40615" variation 2089 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" /replace="a" /replace="g" /db_xref="dbSNP:28364971" polyA_signal 2114..2119 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" polyA_site 2135 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" polyA_signal 2272..2277 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" polyA_site 2305 /gene="CDK20" /gene_synonym="CCRK; CDCH; P42; PNQALRE" ORIGIN
gggggcgggggcagataggaggtgcctgctgtcatcgttccgtgggccctgctgcgggcacgctctcggcgcatgcgttttttatgcgggattaagcttgctgctgcgtgacagcggagggctaggaaaaggcgcagtggggcccggagctgtcacccctgactcgacgcagcttccgttctcctggtgacgtcgcctacaggaaccgccccagtggtcagctgccgcgctgttgctaggcaacagcgtgcgagctcagatcagcgtggggtggaggagaagtggagtttggaagttcaggggcacaggggcacaggcccacgactgcagcgggatggaccagtactgcatcctgggccgcatcggggagggcgcccacggcatcgtcttcaaggccaagcacgtggagactggcgagatagttgccctcaagaaggtggccctaaggcggttggaggacggcttccctaaccaggccctgcgggagattaaggctctgcaggagatggaggacaatcagtatgtggtacaactgaaggctgtgttcccacacggtggaggctttgtgctggcctttgagttcatgctgtcggatctggccgaggtggtgcgccatgcccagaggccactagcccaggcacaggtcaagagctacctgcagatgctgctcaagggtgtcgccttctgccatgccaacaacattgtacatcgggacctgaaacctgccaacctgctcatcagcgcctcaggccagctcaagatagcggactttggcctggctcgagtcttttccccagacggcagccgcctctacacacaccaggtggccaccaggtctgtgggctgcatcatgggggagctgttgaatgggtccccccttttcccgggcaagaacgatattgaacagctttgctatgtgcttcgcatcttgggcaccccaaaccctcaagtctggccggagctcactgagctgccggactacaacaagatctcctttaaggagcaggtgcccatgcccctggaggaggtgctgcctgacgtctctccccaggcattggatctgctgggtcaattccttctctaccctcctcaccagcgcatcgcagcttccaagctcccctgcctgcccatccatctgagctgccgattcctcagcgtctagggggacctgcccccaaggcccatccagggcccccccacatccatgacttccacgtggaccggcctcttgaggagtcgctgttgaacccagagctgattcggcccttcatcctggaggggtgagaagttggccctggtcccgtctgcctgctcctcaggaccactcagtccacctgttcctctgccacctgcctggcttcaccctccaaggcctccccatggccacagtgggcccacaccacaccctgccccttagcccttgcgagggttggtctcgaggcagaggtcatgttcccagccaagagtatgagaacatccagtcgagcagaggagattcatggcctgtgctcggtgagccttaccttctgtgtgctactgacgtacccatcaggacagtgagctctgctgccagtcaaggcctgcatatgcagaatgacgatgcctgccttggtgctgcttccccgagtgctgcctcctggtcaaggagaagtgcagagagtaaggtgtccttatgttggaaactcaagtggaaggaagatttggtttggttttattctcagagccattaaacactagttcagtatgtgagatatagattctaaaaacctcaggtggctctgccttatgtctgttcctccttcatttctctcaagggaaatggctaaggtggcattgtctcatggctctcgtttttggggtcatggggagggtagcaccaggcatagccacttttgccctgagggactcctgtgtacttcacatcactgagcactcatttagaagtgagggagacagaagtctaggcccagggatggctccagttggggatccagcaggagaccctctgcacatgaggctggtttaccaacatctactccctcaggatgagcgtgagccagaagcagctgtgtatttaaggaaacaagcgttcctggaattaatttataaatttaataaatcccaatataatcccagctagtgctttttccttattataatttgataaggtgattataaaagatacatggaaggaagtggaaccagatgcagaagaggaaatgatggaaggacttacggtatcagataccaatatttaaaagtttgtataataataaagagtatgattgtggttcaaggataaaaaaaaaaaaaaa
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:23552 -> Molecular function: GO:0004693 [cyclin-dependent protein serine/threonine kinase activity] evidence: IEA GeneID:23552 -> Molecular function: GO:0005515 [protein binding] evidence: IPI GeneID:23552 -> Molecular function: GO:0005524 [ATP binding] evidence: IEA GeneID:23552 -> Biological process: GO:0007275 [multicellular organismal development] evidence: IEA GeneID:23552 -> Biological process: GO:0051301 [cell division] evidence: IEA GeneID:23552 -> Cellular component: GO:0005634 [nucleus] evidence: IEA GeneID:23552 -> Cellular component: GO:0005737 [cytoplasm] evidence: IEA GeneID:23552 -> Cellular component: GO:0005929 [cilium] evidence: IEA ANNOTATIONS from NCBI Entrez Gene (20130726): NP_001164110 -> EC 2.7.11.22
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.